BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 7505075)

  • 21. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.
    Monga DK; O'Connell MJ
    Ann Surg Oncol; 2006 Aug; 13(8):1021-34. PubMed ID: 16897272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].
    Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B
    Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance and problem of post-operative adjuvant chemotherapy for colorectal cancer].
    Kato T; Hirai T
    Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):396-402. PubMed ID: 9101548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
    Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
    J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities].
    Porschen R; Bermann A
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for colorectal cancer--an overview of current management for surgeons.
    Lawes D; Taylor I
    Eur J Surg Oncol; 2005 Nov; 31(9):932-41. PubMed ID: 15979268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current status of adjuvant therapy in patients with colorectal cancer: report and commentary on the Consensus Conference, 16-18 April 1990, National Cancer Institute, Bethesda, Maryland].
    Steger G; Jakesz R
    Wien Klin Wochenschr; 1991; 103(4):117-21. PubMed ID: 1710398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The present situation regarding postoperative adjuvant chemotherapy].
    Shimada R; Nozawa K; Watanabe T
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1396-402. PubMed ID: 21918334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adjuvant chemotherapy of colorectal carcinoma].
    Casali P; Licitra L; Alafaci E; Gennari L
    Ann Ital Chir; 1990; 61(5):509-13. PubMed ID: 2100969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Improvements in palliative treatment of colorectal carcinoma].
    Wein A; Riedel C; Hanke B; Lampert S; Brückl W; Reingruber B; Hohenberger W; Hahn EG
    Dtsch Med Wochenschr; 2000 Feb; 125(5):121-5. PubMed ID: 10705885
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is there a reliable adjuvant (intraoperative) chemotherapy of colorectal cancer?].
    Hossfeld DK
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():175-8. PubMed ID: 1983550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of colorectal carcinoma in internal medicine].
    Graeven U; Schmiegel W
    Praxis (Bern 1994); 2002 Oct; 91(43):1797-805. PubMed ID: 12432692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Systemic chemotherapy of colorectal cancer--recent approaches].
    Furue H
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):529-34. PubMed ID: 2012395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.